{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T05:08:01Z","timestamp":1795064881631,"version":"4.10.2"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>High-grade serous ovarian carcinoma is characterised by <jats:italic>TP53<\/jats:italic> mutation and extensive chromosome instability (CIN). Because our understanding of CIN mechanisms is based largely on analysing established cell lines, we developed a workflow for generating ex vivo cultures from patient biopsies to provide models that support interrogation of CIN mechanisms in cells not extensively cultured in vitro. Here, we describe a \u201cliving biobank\u201d of ovarian cancer models with extensive replicative capacity, derived from both ascites and solid biopsies. Fifteen models are characterised by p53 profiling, exome sequencing and transcriptomics, and karyotyped using single-cell whole-genome sequencing. Time-lapse microscopy reveals catastrophic and highly heterogeneous mitoses, suggesting that analysis of established cell lines probably underestimates mitotic dysfunction in advanced human cancers. Drug profiling reveals cisplatin sensitivities consistent with patient responses, demonstrating that this workflow has potential to generate personalized avatars with advantages over current pre-clinical models and the potential to guide clinical decision making.<\/jats:p>","DOI":"10.1038\/s41467-020-14551-2","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T11:03:00Z","timestamp":1581591780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity"],"prefix":"10.1038","volume":"11","author":[{"given":"Louisa","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Tighe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2342-4127","authenticated-orcid":false,"given":"Anya","family":"Golder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Littler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7977-8496","authenticated-orcid":false,"given":"Daniela","family":"Moralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Murtuza Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0032-0931","authenticated-orcid":false,"given":"Ian J.","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8403-474X","authenticated-orcid":false,"given":"Diana C. J.","family":"Spierings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Wardenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethanie","family":"Neale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Burghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Winter-Roach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Edmondson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Clamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon C.","family":"Jayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3790-177X","authenticated-orcid":false,"given":"Sudha","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9525-0306","authenticated-orcid":false,"given":"Andy","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0989-3127","authenticated-orcid":false,"given":"Floris","family":"Foijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4621-9326","authenticated-orcid":false,"given":"Stephen S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"14551_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359\u2013E386 (2015).","journal-title":"Int. J. Cancer"},{"key":"14551_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00962-1","volume":"8","author":"SI Labidi-Galy","year":"2017","unstructured":"Labidi-Galy, S. I. et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat. Commun. 8, 1093 (2017).","journal-title":"Nat. Commun."},{"key":"14551_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/path.2091","volume":"211","author":"Y Lee","year":"2007","unstructured":"Lee, Y. et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J. Pathol. 211, 26\u201335 (2007).","journal-title":"J. Pathol."},{"key":"14551_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","volume":"24","author":"R Perets","year":"2013","unstructured":"Perets, R. et al. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. Cancer Cell 24, 751\u2013765 (2013).","journal-title":"Cancer Cell"},{"key":"14551_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/path.1000","volume":"195","author":"JM Piek","year":"2001","unstructured":"Piek, J. M. et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J. Pathol. 195, 451\u2013456 (2001).","journal-title":"J. Pathol."},{"key":"14551_CR6","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux, S., Gourley, C., Vergote, I. & Oza, A. M. Epithelial ovarian cancer. Lancet 393, 1240\u20131253 (2019).","journal-title":"Lancet"},{"key":"14551_CR7","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nrc4019","volume":"15","author":"DD Bowtell","year":"2015","unstructured":"Bowtell, D. D. et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat. Rev. Cancer 15, 668\u2013679 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"14551_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/path.2696","volume":"221","author":"AA Ahmed","year":"2010","unstructured":"Ahmed, A. A. et al. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J. Pathol. 221, 49\u201356 (2010).","journal-title":"J. Pathol."},{"key":"14551_CR9","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/ng.2762","volume":"45","author":"G Ciriello","year":"2013","unstructured":"Ciriello, G. et al. Emerging landscape of oncogenic signatures across human cancers. Nat. Genet. 45, 1127\u20131133 (2013).","journal-title":"Nat. Genet."},{"key":"14551_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research Network.","year":"2011","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609\u2013615 (2011).","journal-title":"Nature"},{"key":"14551_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0526-8","volume":"15","author":"FC Martins","year":"2014","unstructured":"Martins, F. C. et al. Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier. Genome Biol. 15, 526 (2014).","journal-title":"Genome Biol."},{"key":"14551_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature14410","volume":"521","author":"AM Patch","year":"2015","unstructured":"Patch, A. M. et al. Whole-genome characterization of chemoresistant ovarian cancer. Nature 521, 489\u2013494 (2015).","journal-title":"Nature"},{"key":"14551_CR13","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1158\/1078-0432.CCR-16-0564","volume":"23","author":"A McCormick","year":"2017","unstructured":"McCormick, A. et al. Ovarian cancers harbor defects in nonhomologous end joining resulting in resistance to rucaparib. Clin. Cancer Res. 23, 2050\u20132060 (2017).","journal-title":"Clin. Cancer Res."},{"key":"14551_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrclinonc.2017.198","volume":"15","author":"L Sansregret","year":"2018","unstructured":"Sansregret, L., Vanhaesebroeck, B. & Swanton, C. Determinants and clinical implications of chromosomal instability in cancer. Nat. Rev. Clin. Oncol. 15, 139\u2013150 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"14551_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature12625","volume":"501","author":"RA Burrell","year":"2013","unstructured":"Burrell, R. A., McGranahan, N., Bartek, J. & Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501, 338\u2013345 (2013).","journal-title":"Nature"},{"key":"14551_CR16","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1101\/gad.314351.118","volume":"32","author":"MS Levine","year":"2018","unstructured":"Levine, M. S. & Holland, A. J. The impact of mitotic errors on cell proliferation and tumorigenesis. Genes Dev. 32, 620\u2013638 (2018).","journal-title":"Genes Dev."},{"key":"14551_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrm2858","volume":"11","author":"S Negrini","year":"2010","unstructured":"Negrini, S., Gorgoulis, V. G. & Halazonetis, T. D. Genomic instability\u2013an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 11, 220\u2013228 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"14551_CR18","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s41588-018-0179-8","volume":"50","author":"G Macintyre","year":"2018","unstructured":"Macintyre, G. et al. Copy number signatures and mutational processes in ovarian carcinoma. Nat. Genet. 50, 1262\u20131270 (2018).","journal-title":"Nat. Genet."},{"key":"14551_CR19","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3849","volume":"49","author":"YK Wang","year":"2017","unstructured":"Wang, Y. K. et al. Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes. Nat. Genet. 49, 856\u2013865 (2017).","journal-title":"Nat. Genet."},{"key":"14551_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09312-9","volume":"10","author":"EL Christie","year":"2019","unstructured":"Christie, E. L. et al. Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer. Nat. Commun. 10, 1295 (2019).","journal-title":"Nat. Commun."},{"key":"14551_CR21","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1056\/NEJMoa1909707","volume":"381","author":"RL Coleman","year":"2019","unstructured":"Coleman, R. L. et al. Veliparib with first-line chemotherapy and as maintenance therapy in ovarian cancer. N. Engl. J. Med. 381, 2403\u20132415 (2019).","journal-title":"N. Engl. J. Med."},{"key":"14551_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1903387","volume":"381","author":"T Golan","year":"2019","unstructured":"Golan, T. et al. Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. N. Engl. J. Med. 381, 317\u2013327 (2019).","journal-title":"N. Engl. J. Med."},{"key":"14551_CR23","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMoa1910962","volume":"381","author":"A Gonzalez-Martin","year":"2019","unstructured":"Gonzalez-Martin, A. et al. Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. N. Engl. J. Med. 381, 2391\u20132402 (2019).","journal-title":"N. Engl. J. Med."},{"key":"14551_CR24","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJMoa1802905","volume":"379","author":"JK Litton","year":"2018","unstructured":"Litton, J. K. et al. Talazoparib in patients with advanced breast cancer and a germline BRCA mutation. N. Engl. J. Med. 379, 753\u2013763 (2018).","journal-title":"N. Engl. J. Med."},{"key":"14551_CR25","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","volume":"373","author":"J Mateo","year":"2015","unstructured":"Mateo, J. et al. DNA-repair defects and olaparib in metastatic prostate cancer. N. Engl. J. Med. 373, 1697\u20131708 (2015).","journal-title":"N. Engl. J. Med."},{"key":"14551_CR26","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","volume":"379","author":"K Moore","year":"2018","unstructured":"Moore, K. et al. Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. N. Engl. J. Med. 379, 2495\u20132505 (2018).","journal-title":"N. Engl. J. Med."},{"key":"14551_CR27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1706450","volume":"377","author":"M Robson","year":"2017","unstructured":"Robson, M. et al. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N. Engl. J. Med. 377, 523\u2013533 (2017).","journal-title":"N. Engl. J. Med."},{"key":"14551_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3126","volume":"4","author":"S Domcke","year":"2013","unstructured":"Domcke, S., Sinha, R., Levine, D. A., Sander, C. & Schultz, N. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat. Commun. 4, 2126 (2013).","journal-title":"Nat. Commun."},{"key":"14551_CR29","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","volume":"376","author":"M Jamal-Hanjani","year":"2017","unstructured":"Jamal-Hanjani, M. et al. Tracking the evolution of non-small-cell lung cancer. N. Engl. J. Med. 376, 2109\u20132121 (2017).","journal-title":"N. Engl. J. Med."},{"key":"14551_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fonc.2013.00295","volume":"3","author":"CL Scott","year":"2013","unstructured":"Scott, C. L., Becker, M. A., Haluska, P. & Samimi, G. Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment. Front. Oncol. 3, 295 (2013).","journal-title":"Front. Oncol."},{"key":"14551_CR31","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.ajpath.2018.01.019","volume":"188","author":"P Cybulska","year":"2018","unstructured":"Cybulska, P. et al. A genomically characterized collection of high-grade serous ovarian cancer xenografts for preclinical testing. Am. J. Pathol. 188, 1120\u20131131 (2018).","journal-title":"Am. J. Pathol."},{"key":"14551_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs, N. et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell 172, 373\u2013386 e310 (2018).","journal-title":"Cell"},{"key":"14551_CR33","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M van de Wetering","year":"2015","unstructured":"van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933\u2013945 (2015).","journal-title":"Cell"},{"key":"14551_CR34","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1016\/j.celrep.2017.11.051","volume":"21","author":"DP Kodack","year":"2017","unstructured":"Kodack, D. P. et al. Primary patient-derived cancer cells and their potential for personalized cancer patient care. Cell Rep. 21, 3298\u20133309 (2017).","journal-title":"Cell Rep."},{"key":"14551_CR35","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","volume":"25","author":"O Kopper","year":"2019","unstructured":"Kopper, O. et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat. Med. 25, 838\u2013849 (2019).","journal-title":"Nat. Med."},{"key":"14551_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8419","volume":"6","author":"TA Ince","year":"2015","unstructured":"Ince, T. A. et al. Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours. Nat. Commun. 6, 7419 (2015).","journal-title":"Nat. Commun."},{"key":"14551_CR37","doi-asserted-by":"publisher","first-page":"e16186","DOI":"10.1371\/journal.pone.0016186","volume":"6","author":"R Strauss","year":"2011","unstructured":"Strauss, R. et al. Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One 6, e16186 (2011).","journal-title":"PLoS One"},{"key":"14551_CR38","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ccell.2019.02.004","volume":"35","author":"N Pillay","year":"2019","unstructured":"Pillay, N. et al. DNA replication vulnerabilities render ovarian cancer cells sensitive to poly(ADP-Ribose) glycohydrolase inhibitors. Cancer Cell 35, 519\u2013533 e518 (2019).","journal-title":"Cancer Cell"},{"key":"14551_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.devcel.2004.06.006","volume":"7","author":"P Meraldi","year":"2004","unstructured":"Meraldi, P., Draviam, V. M. & Sorger, P. K. Timing and checkpoints in the regulation of mitotic progression. Dev. Cell 7, 45\u201360 (2004).","journal-title":"Dev. Cell"},{"key":"14551_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ccr.2008.07.002","volume":"14","author":"KE Gascoigne","year":"2008","unstructured":"Gascoigne, K. E. & Taylor, S. S. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14, 111\u2013122 (2008).","journal-title":"Cancer Cell"},{"key":"14551_CR41","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1083\/jcb.200712029","volume":"180","author":"SL Thompson","year":"2008","unstructured":"Thompson, S. L. & Compton, D. A. Examining the link between chromosomal instability and aneuploidy in human cells. J. Cell Biol. 180, 665\u2013672 (2008).","journal-title":"J. Cell Biol."},{"key":"14551_CR42","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.cub.2011.05.032","volume":"21","author":"JR Daum","year":"2011","unstructured":"Daum, J. R. et al. Cohesion fatigue induces chromatid separation in cells delayed at metaphase. Curr. Biol. 21, 1018\u20131024 (2011).","journal-title":"Curr. Biol."},{"key":"14551_CR43","doi-asserted-by":"publisher","first-page":"e22969","DOI":"10.1371\/journal.pone.0022969","volume":"6","author":"D Stevens","year":"2011","unstructured":"Stevens, D., Gassmann, R., Oegema, K. & Desai, A. Uncoordinated loss of chromatid cohesion is a common outcome of extended metaphase arrest. PLoS One 6, e22969 (2011).","journal-title":"PLoS One"},{"key":"14551_CR44","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2018.07.042","volume":"175","author":"KA Knouse","year":"2018","unstructured":"Knouse, K. A., Lopez, K. E., Bachofner, M. & Amon, A. Chromosome segregation fidelity in epithelia requires tissue architecture. Cell 175, 200\u2013211 e213 (2018).","journal-title":"Cell"},{"key":"14551_CR45","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1158\/2159-8290.CD-18-0474","volume":"8","author":"SJ Hill","year":"2018","unstructured":"Hill, S. J. et al. Prediction of DNA repair inhibitor response in short-term patient-derived ovarian cancer organoids. Cancer Discov. 8, 1404\u20131421 (2018).","journal-title":"Cancer Discov."},{"key":"14551_CR46","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cell.2006.01.045","volume":"125","author":"C Norden","year":"2006","unstructured":"Norden, C. et al. The NoCut pathway links completion of cytokinesis to spindle midzone function to prevent chromosome breakage. Cell 125, 85\u201398 (2006).","journal-title":"Cell"},{"key":"14551_CR47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.cell.2008.12.020","volume":"136","author":"P Steigemann","year":"2009","unstructured":"Steigemann, P. et al. Aurora B-mediated abscission checkpoint protects against tetraploidization. Cell 136, 473\u2013484 (2009).","journal-title":"Cell"},{"key":"14551_CR48","doi-asserted-by":"publisher","first-page":"E644","DOI":"10.3390\/cells8070644","volume":"8","author":"FI Ghani","year":"2019","unstructured":"Ghani, F. I. et al. An ex-vivo culture system of ovarian cancer faithfully recapitulating the pathological features of primary tumors. Cells 8, E644 (2019).","journal-title":"Cells"},{"key":"14551_CR49","doi-asserted-by":"publisher","first-page":"50489","DOI":"10.18632\/oncotarget.9929","volume":"8","author":"KL Thu","year":"2017","unstructured":"Thu, K. L. et al. A comprehensively characterized cell line panel highly representative of clinical ovarian high-grade serous carcinomas. Oncotarget 8, 50489\u201350499 (2017).","journal-title":"Oncotarget"},{"key":"14551_CR50","doi-asserted-by":"publisher","first-page":"e1006707","DOI":"10.1371\/journal.pgen.1006707","volume":"13","author":"S Penner-Goeke","year":"2017","unstructured":"Penner-Goeke, S. et al. The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples. PLoS Genet. 13, e1006707 (2017).","journal-title":"PLoS Genet."},{"key":"14551_CR51","doi-asserted-by":"publisher","first-page":"e46858","DOI":"10.1371\/journal.pone.0046858","volume":"7","author":"A Latifi","year":"2012","unstructured":"Latifi, A. et al. Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors. PLoS One 7, e46858 (2012).","journal-title":"PLoS One"},{"key":"14551_CR52","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/carcin\/bgy068","volume":"39","author":"D Wangsa","year":"2018","unstructured":"Wangsa, D. et al. The evolution of single cell-derived colorectal cancer cell lines is dominated by the continued selection of tumor-specific genomic imbalances, despite random chromosomal instability. Carcinogenesis 39, 993\u20131005 (2018).","journal-title":"Carcinogenesis"},{"key":"14551_CR53","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00262-018-2211-3","volume":"67","author":"GL Owens","year":"2018","unstructured":"Owens, G. L. et al. Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells. Cancer Immunol. Immunother. 67, 1519\u20131531 (2018).","journal-title":"Cancer Immunol. Immunother."},{"key":"14551_CR54","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ccell.2015.06.001","volume":"28","author":"C Topham","year":"2015","unstructured":"Topham, C. et al. MYC is a major determinant of mitotic cell fate. Cancer Cell 28, 129\u2013140 (2015).","journal-title":"Cancer Cell"},{"key":"14551_CR55","doi-asserted-by":"publisher","first-page":"190136","DOI":"10.1098\/rsob.190136","volume":"9","author":"S Littler","year":"2019","unstructured":"Littler, S. et al. Oncogenic MYC amplifies mitotic perturbations. Open Biol. 9, 190136 (2019).","journal-title":"Open Biol."},{"key":"14551_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00263-7","volume":"8","author":"IK Zervantonakis","year":"2017","unstructured":"Zervantonakis, I. K. et al. Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response. Nat. Commun. 8, 365 (2017).","journal-title":"Nat. Commun."},{"key":"14551_CR57","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00412-010-0261-1","volume":"119","author":"FG Westhorpe","year":"2010","unstructured":"Westhorpe, F. G., Diez, M. A., Gurden, M. D., Tighe, A. & Taylor, S. S. Re-evaluating the role of Tao1 in the spindle checkpoint. Chromosoma 119, 371\u2013379 (2010).","journal-title":"Chromosoma"},{"key":"14551_CR58","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.chembiol.2008.04.013","volume":"15","author":"F Girdler","year":"2008","unstructured":"Girdler, F. et al. Molecular basis of drug resistance in aurora kinases. Chem. Biol. 15, 552\u2013562 (2008).","journal-title":"Chem. Biol."},{"key":"14551_CR59","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"14551_CR60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"14551_CR61","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1101\/gr.135350.111","volume":"22","author":"J Harrow","year":"2012","unstructured":"Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 22, 1760\u20131774 (2012).","journal-title":"Genome Res"},{"key":"14551_CR62","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"14551_CR63","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"14551_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"14551_CR65","first-page":"D626","volume":"45","author":"C Tyner","year":"2017","unstructured":"Tyner, C. et al. The UCSC Genome Browser database: 2017 update. Nucleic Acids Res. 45, D626\u2013D634 (2017).","journal-title":"Nucleic Acids Res."},{"key":"14551_CR66","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589\u2013595 (2010).","journal-title":"Bioinformatics"},{"key":"14551_CR67","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2013.09.006","volume":"155","author":"DC Koboldt","year":"2013","unstructured":"Koboldt, D. C., Steinberg, K. M., Larson, D. E., Wilson, R. K. & Mardis, E. R. The next-generation sequencing revolution and its impact on genomics. Cell 155, 27\u201338 (2013).","journal-title":"Cell"},{"key":"14551_CR68","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576 (2012).","journal-title":"Genome Res."},{"key":"14551_CR69","doi-asserted-by":"publisher","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","volume":"45","author":"SA Forbes","year":"2017","unstructured":"Forbes, S. A. et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res. 45, D777\u2013D783 (2017).","journal-title":"Nucleic Acids Res."},{"key":"14551_CR70","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"14551_CR71","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsdottir","year":"2013","unstructured":"Thorvaldsdottir, H., Robinson, J. T. & Mesirov, J. P. Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 14, 178\u2013192 (2013).","journal-title":"Brief Bioinform."},{"key":"14551_CR72","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nmeth.2967","volume":"11","author":"PV Kharchenko","year":"2014","unstructured":"Kharchenko, P. V., Silberstein, L. & Scadden, D. T. Bayesian approach to single-cell differential expression analysis. Nat. Methods 11, 740\u2013742 (2014).","journal-title":"Nat. Methods"},{"key":"14551_CR73","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nmeth.3734","volume":"13","author":"J Fan","year":"2016","unstructured":"Fan, J. et al. Characterizing transcriptional heterogeneity through pathway and gene set overdispersion analysis. Nat. Methods 13, 241\u2013244 (2016).","journal-title":"Nat. Methods"},{"key":"14551_CR74","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymeth.2015.06.021","volume":"85","author":"A Scialdone","year":"2015","unstructured":"Scialdone, A. et al. Computational assignment of cell-cycle stage from single-cell transcriptome data. Methods 85, 54\u201361 (2015).","journal-title":"Methods"},{"key":"14551_CR75","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"14551_CR76","doi-asserted-by":"publisher","first-page":"e21800","DOI":"10.1371\/journal.pone.0021800","volume":"6","author":"F Supek","year":"2011","unstructured":"Supek, F., Bosnjak, M., Skunca, N. & Smuc, T. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS One 6, e21800 (2011).","journal-title":"PLoS One"},{"key":"14551_CR77","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"14551_CR78","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1093\/bioinformatics\/btq562","volume":"26","author":"J Montojo","year":"2010","unstructured":"Montojo, J. et al. GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop. Bioinformatics 26, 2927\u20132928 (2010).","journal-title":"Bioinformatics"},{"key":"14551_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0947-7","volume":"17","author":"AT Lun","year":"2016","unstructured":"Lun, A. T., Bach, K. & Marioni, J. C. Pooling across cells to normalize single-cell RNA sequencing data with many zero counts. Genome Biol. 17, 75 (2016).","journal-title":"Genome Biol."},{"key":"14551_CR80","doi-asserted-by":"publisher","first-page":"9546","DOI":"10.1073\/pnas.0914005107","volume":"107","author":"R Bourgon","year":"2010","unstructured":"Bourgon, R., Gentleman, R. & Huber, W. Independent filtering increases detection power for high-throughput experiments. Proc. Natl Acad. Sci. USA 107, 9546\u20139551 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"14551_CR81","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/bioinformatics\/btm563","volume":"24","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P., Zhang, B. & Horvath, S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics 24, 719\u2013720 (2008).","journal-title":"Bioinformatics"},{"key":"14551_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0971-7","volume":"17","author":"B Bakker","year":"2016","unstructured":"Bakker, B. et al. Single-cell sequencing reveals karyotype heterogeneity in murine and human malignancies. Genome Biol. 17, 115 (2016).","journal-title":"Genome Biol."},{"key":"14551_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0976-2","volume":"17","author":"H van den Bos","year":"2016","unstructured":"van den Bos, H. et al. Single-cell whole genome sequencing reveals no evidence for common aneuploidy in normal and Alzheimer\u2019s disease neurons. Genome Biol. 17, 116 (2016).","journal-title":"Genome Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14551-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14551-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14551-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T18:15:14Z","timestamp":1670264114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14551-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["14551"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-14551-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,13]]},"assertion":[{"value":"21 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"822"}}